Quest Diagnostics (DGX) Total Non-Current Liabilities (2009 - 2026)

Quest Diagnostics (DGX) has 18 years of Total Non-Current Liabilities data on file, last reported at $8.0 billion in Q1 2026.

• Quarterly Total Non-Current Liabilities rose 0.85% year-over-year to $8.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.0 billion (up 0.85% YoY) and the FY2025 annual result came in at $8.1 billion, down 3.62% from the prior year.
• Total Non-Current Liabilities fell to $8.0 billion in Q1 2026 per DGX's latest filing, from $8.1 billion in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $8.4 billion in Q4 2024, with the low at $5.9 billion in Q1 2023.
• Average Total Non-Current Liabilities over 5 years is $7.1 billion, with a median of $7.0 billion recorded in 2023.
• Year-over-year, Total Non-Current Liabilities retreated 6.17% in 2023 and soared 36.09% in 2024.
• Quest Diagnostics' Total Non-Current Liabilities stood at $6.1 billion in 2022, then climbed by 11.63% to $6.8 billion in 2023, then grew by 23.49% to $8.4 billion in 2024, then dropped by 3.62% to $8.1 billion in 2025, then slipped by 1.4% to $8.0 billion in 2026.
• Business Quant data shows DGX's Total Non-Current Liabilities at $8.0 billion in Q1 2026, $8.1 billion in Q4 2025, and $8.0 billion in Q3 2025.